Reply

We appreciate the insight of Dr. Harrington et  al regarding the successful implementation of topical rectal antiseptic (TRS) into their transrectal prostate biopsy protocol, and commend them for the associated reduction in infectious complications over the decade of their experience. Their study, a retrospective review of nearly 1200 men who u nderwent transrectal biopsy of the prostate, compared a cohort that received TRS with antibiotic prophylaxis relative to a cohort that received antibiotic prophylaxis but no TRS.
Source: Urology - Category: Urology & Nephrology Authors: Source Type: research